Related Experiment Video

Updated: Jul 15, 2026

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants
07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

The AKT-mTOR pathway plays a critical role in the development of leiomyosarcomas

Eva Hernando1, Elizabeth Charytonowicz, Maria E Dudas

  • 1Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA.

Nature Medicine
|May 15, 2007
PubMed

Insights

Aberrant PI3K-AKT signaling drives leiomyosarcoma development. Targeting the AKT-mTOR pathway with everolimus slowed tumor growth in mice, suggesting therapeutic potential for sarcomas.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • The PI3K-AKT signaling pathway is frequently dysregulated in various cancers.
  • Leiomyosarcomas are aggressive soft tissue tumors with poorly understood molecular drivers.
  • Insulin receptor substrate-2 (IRS2) and phosphorylated AKT are upregulated in leiomyosarcomas.

Purpose of the Study:

  • To investigate the role of the PI3K-AKT pathway in leiomyosarcoma pathogenesis.
  • To establish a genetically engineered mouse model for leiomyosarcoma.
  • To evaluate the therapeutic potential of targeting the AKT-mTOR pathway.

Main Methods:

  • Analysis of PI3K-AKT signaling cascade in sarcoma cohorts.
  • Genetic inactivation of Pten in mouse smooth muscle cells using Tagln-cre and Pten(loxP/loxP) mice.
  • Treatment of tumor-bearing mice with the mTOR inhibitor everolimus.

Main Results:

  • Pten deletion in smooth muscle cells led to hyperplasia and high-incidence leiomyosarcomas (approx. 80%) with rapid onset.
  • Constitutive mTOR activation was observed specifically in leiomyosarcomas, indicating Pten loss is necessary but not sufficient.
  • Everolimus treatment significantly decelerated tumor growth and prolonged lifespan in the mouse model.

Conclusions:

  • The AKT-mTOR pathway plays a critical role in smooth muscle transformation and leiomyosarcoma genesis.
  • Targeting the AKT-mTOR pathway represents a promising therapeutic strategy for leiomyosarcomas.
  • Combination therapies involving AKT-mTOR inhibitors and conventional agents may benefit sarcoma patients.

More Related Videos

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer06:51

Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer

Published on: July 21, 2018

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration11:13

Exploring the Pharmacological Action and Molecular Mechanism of Salidroside in Inhibiting MCF-7 Cell Proliferation and Migration

Published on: June 9, 2023

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...